Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART.

Upadhya B, Rocco MV, Pajewski NM, Morgan T, Blackshear J, Hundley WG, Oparil S, Soliman EZ, Cohen DL, Hamilton CA, Cho ME, Kostis WJ, Papademetriou V, Rodriguez CJ, Raj DS, Townsend R, Vasu S, Zamanian S, Kitzman DW; SPRINT Research Group * .

Hypertension. 2019 Jul 1:HYPERTENSIONAHA11913073. doi: 10.1161/HYPERTENSIONAHA.119.13073. [Epub ahead of print]

PMID:
31256724
2.

Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.

Weber MA, Mahfoud F, Schmieder RE, Kandzari DE, Tsioufis KP, Townsend RR, Kario K, Böhm M, Sharp ASP, Davies JE, Osborn JW, Fink GD, Euler DE, Cohen DL, Schlaich MP, Esler MD.

JACC Cardiovasc Interv. 2019 Jun 24;12(12):1095-1105. doi: 10.1016/j.jcin.2019.02.050. Review.

PMID:
31221299
3.

Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis.

Cohen JB, Lotito MJ, Trivedi UK, Denker MG, Cohen DL, Townsend RR.

Ann Intern Med. 2019 Jun 18;170(12):853-862. doi: 10.7326/M19-0223. Epub 2019 Jun 11.

PMID:
31181575
4.

Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial.

Rodgers H, Bosomworth H, Krebs HI, van Wijck F, Howel D, Wilson N, Aird L, Alvarado N, Andole S, Cohen DL, Dawson J, Fernandez-Garcia C, Finch T, Ford GA, Francis R, Hogg S, Hughes N, Price CI, Ternent L, Turner DL, Vale L, Wilkes S, Shaw L.

Lancet. 2019 Jul 6;394(10192):51-62. doi: 10.1016/S0140-6736(19)31055-4. Epub 2019 May 22.

5.

MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.

Kim E, Zucconi BE, Wu M, Nocco SE, Meyers DJ, McGee JS, Venkatesh S, Cohen DL, Gonzalez EC, Ryu B, Cole PA, Alani RM.

Cancer Res. 2019 May 15;79(10):2649-2661. doi: 10.1158/0008-5472.CAN-18-2331. Epub 2019 Mar 25.

PMID:
30910803
6.

Culturing echinoderm larvae through metamorphosis.

Hodin J, Heyland A, Mercier A, Pernet B, Cohen DL, Hamel JF, Allen JD, McAlister JS, Byrne M, Cisternas P, George SB.

Methods Cell Biol. 2019;150:125-169. doi: 10.1016/bs.mcb.2018.11.004. Epub 2018 Dec 27. Review.

PMID:
30777174
7.

Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.

Chen J, Bundy JD, Hamm LL, Hsu CY, Lash J, Miller ER 3rd, Thomas G, Cohen DL, Weir MR, Raj DS, Chen HY, Xie D, Rao P, Wright JT Jr, Rahman M, He J.

Hypertension. 2019 Apr;73(4):785-793. doi: 10.1161/HYPERTENSIONAHA.118.12358.

PMID:
30776971
8.

Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Nanba K, Omata K, Gomez-Sanchez CE, Stratakis CA, Demidowich AP, Suzuki M, Thompson LDR, Cohen DL, Luther JM, Gellert L, Vaidya A, Barletta JA, Else T, Giordano TJ, Tomlins SA, Rainey WE.

Hypertension. 2019 Apr;73(4):885-892. doi: 10.1161/HYPERTENSIONAHA.118.12070.

PMID:
30739536
9.

Primary aldosteronism with nonlocalizing imaging.

Wachtel H, Bhandari S, Roses RE, Cohen DL, Trerotola SO, Fraker DL.

Surgery. 2019 Jan;165(1):211-218. doi: 10.1016/j.surg.2018.04.077. Epub 2018 Nov 7.

PMID:
30413318
10.

Sleep duration and 24-hour ambulatory blood pressure in adults not on antihypertensive medications.

Shulman R, Cohen DL, Grandner MA, Gislason T, Pack AI, Kuna ST, Townsend RR, Cohen JB.

J Clin Hypertens (Greenwich). 2018 Dec;20(12):1712-1720. doi: 10.1111/jch.13416. Epub 2018 Oct 30.

11.

Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults.

Dobre M, Gaussoin SA, Bates JT, Chonchol MB, Cohen DL, Hostetter TH, Raphael KL, Taylor AA, Lerner AJ, Wright JT Jr, Rahman M; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):596-603. doi: 10.2215/CJN.07050717. Epub 2018 Mar 22.

12.

Central Blood Pressure and Cardiovascular Outcomes in Chronic Kidney Disease.

Rahman M, Hsu JY, Desai N, Hsu CY, Anderson AH, Appel LJ, Chen J, Cohen DL, Drawz PE, He J, Qiang P, Ricardo AC, Steigerwalt S, Weir MR, Wright JT Jr, Zhang X, Townsend RR; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):585-595. doi: 10.2215/CJN.08620817. Epub 2018 Feb 23.

13.

Approach to the Young Patient with New-Onset Hypertension.

Cohen DL, Townsend RR.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):929-932. doi: 10.2215/CJN.13341217. Epub 2018 Feb 23. No abstract available.

14.

Randomised, double-blind, placebo-controlled crossover study of single-dose guanfacine in unilateral neglect following stroke.

Dalmaijer ES, Li KMS, Gorgoraptis N, Leff AP, Cohen DL, Parton AD, Husain M, Malhotra PA.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):593-598. doi: 10.1136/jnnp-2017-317338. Epub 2018 Feb 7.

15.

Blood pressure readings using public kiosks or smart phone apps: Caveat emptor (for now).

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2017 Oct;19(10):946-947. doi: 10.1111/jch.13013. Epub 2017 Sep 24. No abstract available.

16.

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.

Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M; SPYRAL HTN-OFF MED trial investigators*.

Lancet. 2017 Nov 11;390(10108):2160-2170. doi: 10.1016/S0140-6736(17)32281-X. Epub 2017 Aug 28.

PMID:
28859944
17.

Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial.

Woodhouse LJ, Scutt P, Hamdy S, Smithard DG, Cohen DL, Roffe C, Bereczki D, Berge E, Bladin CF, Caso V, Christensen HK, Collins R, Czlonkowska A, de Silva A, Etribi A, Laska AC, Ntaios G, Ozturk S, Phillips SJ, Prasad K, Szatmari S, Sprigg N, Bath PM.

Transl Stroke Res. 2018 Apr;9(2):120-129. doi: 10.1007/s12975-017-0548-0. Epub 2017 Aug 2.

18.

Robot Assisted Training for the Upper Limb after Stroke (RATULS): study protocol for a randomised controlled trial.

Rodgers H, Shaw L, Bosomworth H, Aird L, Alvarado N, Andole S, Cohen DL, Dawson J, Eyre J, Finch T, Ford GA, Hislop J, Hogg S, Howel D, Hughes N, Krebs HI, Price C, Rochester L, Stamp E, Ternent L, Turner D, Vale L, Warburton E, van Wijck F, Wilkes S.

Trials. 2017 Jul 20;18(1):340. doi: 10.1186/s13063-017-2083-4.

19.

SDHB mutation carriers with malignant pheochromocytoma respond better to CVD.

Fishbein L, Ben-Maimon S, Keefe S, Cengel K, Pryma DA, Loaiza-Bonilla A, Fraker DL, Nathanson KL, Cohen DL.

Endocr Relat Cancer. 2017 Aug;24(8):L51-L55. doi: 10.1530/ERC-17-0086. Epub 2017 May 31. No abstract available.

PMID:
28566531
20.

Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.

Maxwell AE, MacLeod MJ, Joyson A, Johnson S, Ramadan H, Bellfield R, Byrne A, McGhee C, Rudd A, Price F, Vasileiadis E, Holden M, Hewitt J, Carpenter M, Needle A, Valentine S, Patel F, Harrington F, Mudd P, Emsley H, Gregary B, Kane I, Muir K, Tiwari D, Owusu-Agyei P, Temple N, Sekaran L, Ragab S, England T, Hedstrom A, Jones P, Jones S, Doherty M, McCarron MO, Cohen DL, Tysoe S, Al-Shahi Salman R.

Trials. 2017 Apr 5;18(1):162. doi: 10.1186/s13063-017-1909-4.

21.

Adrenal Vein Sampling for Primary Aldosteronism: A 2-Week Protocol for Withdrawal of Renin-Stimulating Antihypertensives.

Ching KC, Cohen DL, Fraker DL, Trerotola SO.

Cardiovasc Intervent Radiol. 2017 Sep;40(9):1367-1371. doi: 10.1007/s00270-017-1637-x. Epub 2017 Apr 4.

PMID:
28378050
22.

Lateralization index but not contralateral suppression at adrenal vein sampling predicts improvement in blood pressure after adrenalectomy for primary aldosteronism.

Tagawa M, Ghosn M, Wachtel H, Fraker D, Townsend RR, Trerotola S, Cohen DL.

J Hum Hypertens. 2017 Jul;31(7):444-449. doi: 10.1038/jhh.2016.92. Epub 2017 Jan 12.

PMID:
28079049
23.

Hypertension in 2016: Blood pressure goals, variability and SGLT2 blockade in CKD.

Cohen DL, Townsend RR.

Nat Rev Nephrol. 2017 Feb;13(2):75-76. doi: 10.1038/nrneph.2016.189. Epub 2016 Dec 28. Review. No abstract available.

PMID:
28029152
24.

Stroke.

Cohen DL, Bathula R, Devine J.

Clin Med (Lond). 2016 Dec;16(Suppl 6):s49-s52. Review.

25.

Recognition and Management of Resistant Hypertension.

Braam B, Taler SJ, Rahman M, Fillaus JA, Greco BA, Forman JP, Reisin E, Cohen DL, Saklayen MG, Hedayati SS.

Clin J Am Soc Nephrol. 2017 Mar 7;12(3):524-535. doi: 10.2215/CJN.06180616. Epub 2016 Nov 28. Review.

26.

Blood pressure in patients with atrial fibrillation: part 2-treatment.

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2017 Feb;19(2):212-214. doi: 10.1111/jch.12939. Epub 2016 Oct 21. No abstract available.

27.

Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension.

Cohen JB, Cohen DL.

Curr Cardiol Rep. 2016 Nov;18(11):112. Review.

28.

Orthostatic changes in systolic blood pressure among SPRINT participants at baseline.

Townsend RR, Chang TI, Cohen DL, Cushman WC, Evans GW, Glasser SP, Haley WE, Olney C, Oparil S, Del Pinto R, Pisoni R, Taylor AA, Umanath K, Wright JT Jr, Yeboah J; SPRINT Study Research Group.

J Am Soc Hypertens. 2016 Nov;10(11):847-856. doi: 10.1016/j.jash.2016.08.005. Epub 2016 Aug 26.

29.

Blood Pressure in Patients With Atrial Fibrillation: Part 1--Measurement.

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2017 Jan;19(1):98-99. doi: 10.1111/jch.12905. Epub 2016 Aug 20. No abstract available.

30.

Medication Non-Adherence: A Bigger Problem Than Physicians Assume.

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2016 Sep;18(9):949-50. doi: 10.1111/jch.12838. Epub 2016 May 12. No abstract available.

31.

Hand washing is all about respect for patients.

Cohen DL.

BMJ Qual Saf. 2016 Jun;25(6):475. doi: 10.1136/bmjqs-2016-005538. Epub 2016 Apr 19. No abstract available.

PMID:
27095852
32.

Resistant Hypertension and Renal Nerve Denervation.

Denker MG, Cohen DL.

Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):240-4. doi: 10.14797/mdcj-11-4-240. Review.

33.

Post-stroke dysphagia: A review and design considerations for future trials.

Cohen DL, Roffe C, Beavan J, Blackett B, Fairfield CA, Hamdy S, Havard D, McFarlane M, McLauglin C, Randall M, Robson K, Scutt P, Smith C, Smithard D, Sprigg N, Warusevitane A, Watkins C, Woodhouse L, Bath PM.

Int J Stroke. 2016 Jun;11(4):399-411. doi: 10.1177/1747493016639057. Epub 2016 Mar 22. Review.

PMID:
27006423
34.

Anemia and risk for cognitive decline in chronic kidney disease.

Kurella Tamura M, Vittinghoff E, Yang J, Go AS, Seliger SL, Kusek JW, Lash J, Cohen DL, Simon J, Batuman V, Ordonez J, Makos G, Yaffe K.

BMC Nephrol. 2016 Jan 28;17:13. doi: 10.1186/s12882-016-0226-6.

35.

Role of adrenal vein sampling in primary aldosteronism: Impact of imaging, localization, and age.

Wachtel H, Zaheer S, Shah PK, Trerotola SO, Karakousis GC, Roses RE, Cohen DL, Fraker DL.

J Surg Oncol. 2016 Apr;113(5):532-7. doi: 10.1002/jso.24182. Epub 2016 Jan 21.

PMID:
26792453
36.

Blood Pressure Effects of Yoga, Alone or in Combination With Lifestyle Measures: Results of the Lifestyle Modification and Blood Pressure Study (LIMBS).

Cohen DL, Boudhar S, Bowler A, Townsend RR.

J Clin Hypertens (Greenwich). 2016 Aug;18(8):809-16. doi: 10.1111/jch.12772. Epub 2016 Jan 15.

37.

Which Patients Does the SPRINT Study Not Apply To and What Are the Appropriate Blood Pressure Goals in These Populations?

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2016 May;18(5):477-8. doi: 10.1111/jch.12766. Epub 2016 Jan 6. No abstract available.

38.

Beyond Blood Pressure: Percutaneous Renal Denervation for the Management of Sympathetic Hyperactivity and Associated Disease States.

McArdle MJ, deGoma EM, Cohen DL, Townsend RR, Wilensky RL, Giri J.

J Am Heart Assoc. 2016 Jan 4;5(3):e001415. doi: 10.1161/JAHA.114.001415. Review. No abstract available.

39.

The Stories Clinicians Tell: Achieving High Reliability and Improving Patient Safety.

Cohen DL, Stewart KO.

Perm J. 2016 Winter;20(1):85-90. doi: 10.7812/TPP/15-039. Epub 2015 Nov 9.

40.

Preoperative Metyrosine Improves Cardiovascular Outcomes for Patients Undergoing Surgery for Pheochromocytoma and Paraganglioma.

Wachtel H, Kennedy EH, Zaheer S, Bartlett EK, Fishbein L, Roses RE, Fraker DL, Cohen DL.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S646-54. doi: 10.1245/s10434-015-4862-z. Epub 2015 Sep 15.

PMID:
26374407
41.

Around 9% of patients with ischaemic stroke are suitable for thrombectomy.

Cohen DL, Kearney R, Griffiths M, Nadesalingam V, Bathula R.

BMJ. 2015 Aug 28;351:h4607. doi: 10.1136/bmj.h4607. No abstract available.

PMID:
26318160
42.

What Is Happening in the Area of Device-Based Blood Pressure Treatment?

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2016 Mar;18(3):247. doi: 10.1111/jch.12655. Epub 2015 Aug 21. No abstract available.

43.

Catheter-based Renal Artery Denervation for Resistant Hypertension: Promise Unfulfilled or Unsettled?

Denker MG, Cohen DL, Townsend RR.

Curr Atheroscler Rep. 2015 Oct;17(10):56. doi: 10.1007/s11883-015-0535-4. Review.

PMID:
26289114
44.

Ambulatory Arterial Stiffness Index and circadian blood pressure variability.

Bahrainwala J, Patel A, Diaz KM, Veerabhadrappa P, Cohen DL, Cucchiara A, Townsend RR.

J Am Soc Hypertens. 2015 Sep;9(9):705-10. doi: 10.1016/j.jash.2015.07.001. Epub 2015 Jul 9.

PMID:
26260424
45.

Catecholamine excess: pseudopheochromocytoma and beyond.

Garcha AS, Cohen DL.

Adv Chronic Kidney Dis. 2015 May;22(3):218-23. doi: 10.1053/j.ackd.2014.11.002. Review.

PMID:
25908471
46.

Antihypertensive Medications in End-Stage Renal Disease.

Denker MG, Cohen DL.

Semin Dial. 2015 Jul-Aug;28(4):330-6. doi: 10.1111/sdi.12369. Epub 2015 Apr 15.

PMID:
25877881
47.

Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.

Cohen JB, Cohen DL.

Curr Hypertens Rep. 2015 May;17(5):34. doi: 10.1007/s11906-015-0544-2. Review.

48.

Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.

McArdle MJ, deGoma EM, Cohen DL, Townsend RR, Wilensky RL, Giri J.

J Am Heart Assoc. 2015 Mar 23;4(3):e001415. doi: 10.1161/JAHA.114.001415. Review. No abstract available.

49.

Should all patients have ambulatory blood pressure monitoring performed to validate the diagnosis of hypertension?

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2015 May;17(5):412-3. doi: 10.1111/jch.12527. Epub 2015 Mar 10. No abstract available.

50.

The heterogeneity and diversity of hypertension in CKD.

Goldman JM, Cohen DL, Sim JJ.

Adv Chronic Kidney Dis. 2015 Mar;22(2):86-7. doi: 10.1053/j.ackd.2014.12.003. No abstract available.

PMID:
25704343

Supplemental Content

Loading ...
Support Center